Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
GALNT10 encodes a member of the GalNAc polypeptide N-acetylgalactosaminyltransferases. Additionally we are shipping GALNT10 Proteins (6) and GALNT10 Kits (1) and many more products for this protein.
Showing 10 out of 49 products:
Human Polyclonal GALNT10 Primary Antibody for EIA, IHC (p) - ABIN499865
Amado, Almeida, Schwientek, Clausen: Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. in Biochimica et biophysica acta 2000
Show all 2 references for ABIN499865
Human Polyclonal GALNT10 Primary Antibody for EIA, IHC (p) - ABIN499867
Nelson, Sutcliffe, Thomas: A new UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase mRNA exhibits predominant expression in the hypothalamus, thalamus and amygdala of mouse forebrain. in Brain research. Gene expression patterns 2004
Show all 2 references for ABIN499867
Human Polyclonal GALNT10 Primary Antibody for WB - ABIN2783507
Cheng, Tachibana, Zhang, Guo, Kahori Tachibana, Kameyama, Wang, Hiruma, Iwasaki, Togayachi, Kudo, Narimatsu: Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10. in FEBS letters 2002
GALNT10 exhibits predominant expression in the hypothalamus, thalamus and amygdala of mouse forebrain
Elevated Expression of N-Acetylgalactosaminyltransferase (show B4GALNT2 Antibodies) 10 is associated with early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma (show MOK Antibodies).
SNPs in LEKR1 and GALNT10 modulate sex-difference in carotid intima-media thickness.
our results reveal a novel Hnf4alpha (show HNF4A Antibodies)/miR (show MLXIP Antibodies)-122/GALNT10 regulatory pathway that facilitates EGF (show EGF Antibodies) miR (show MLXIP Antibodies)-122 activation and hepatoma growth in HBV-associated hepatocarcinogenesis.
Molecular cloning and characterization of pp-GalNAc-T10 as a UDP-GalNAc (show Galnt1 Antibodies) transferase.
GalNAc T10 has a large and pronounced glycopeptide preference for Ser (show SIGLEC1 Antibodies)/Thr (show TRH Antibodies)-O-GalNAc only at the +1 position from the acceptor site, whereas T1 and T2 have significantly reduced and variable preferences for Ser (show SIGLEC1 Antibodies)/Thr (show TRH Antibodies)-O-GalNAc.
This gene encodes a member of the GalNAc polypeptide N-acetylgalactosaminyltransferases. These enzymes catalyze the first step in the synthesis of mucin-type oligosaccharides. These proteins transfer GalNAc from UDP-GalNAc to either serine or threonine residues of polypeptide acceptors. The protein encoded by this locus may have increased catalytic activity toward glycosylated peptides compared to activity toward non-glycosylated peptides.
UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10
, UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 9
, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9
, polypeptide GalNAc transferase 10
, polypeptide N-acetylgalactosaminyltransferase 10
, pp-GaNTase 10
, protein-UDP acetylgalactosaminyltransferase 10
, GalNAc transferase 10